| IL-6 and IL-8 are linked with myeloid-derived suppressor cell accumulation and correlate with poor clinical outcomes in melanoma patients RP Tobin, KR Jordan, P Kapoor, E Spongberg, D Davis, VM Vorwald, ... Frontiers in oncology 9, 1223, 2019 | 117 | 2019 |
| Habitual aerobic exercise does not protect against micro-or macrovascular endothelial dysfunction in healthy estrogen-deficient postmenopausal women JR Santos-Parker, TR Strahler, VM Vorwald, GL Pierce, DR Seals Journal of Applied Physiology 122 (1), 11-19, 2017 | 75 | 2017 |
| Targeting MDSC differentiation using ATRA: a phase I/II clinical trial combining pembrolizumab and all-trans retinoic acid for metastatic melanoma RP Tobin, DT Cogswell, VM Cates, DM Davis, JSW Borgers, ... Clinical Cancer Research 29 (7), 1209-1219, 2023 | 34 | 2023 |
| Targeting MDSCs using ATRA: a phase I/II clinical trial combining pembrolizumab and all-trans retinoic acid for metastatic melanoma R Tobin, D Cogswell, V Vorwald, D Davis, J Borgers, R Van Gulick, ... | 34* | 2021 |
| Pre-treatment mutational and transcriptomic landscape of responding metastatic melanoma patients to anti-PD1 immunotherapy CM Amato, JD Hintzsche, K Wells, A Applegate, NT Gorden, VM Vorwald, ... Cancers 12 (7), 1943, 2020 | 26 | 2020 |
| Gamification and game-based strategies for dermatology education: Narrative review MD Szeto, D Strock, J Anderson, TE Sivesind, VM Vorwald, HR Rietcheck, ... JMIR Dermatology 4 (2), e30325, 2021 | 24 | 2021 |
| Circulating CD8+ mucosal‐associated invariant T cells correlate with improved treatment responses and overall survival in anti‐PD‐1‐treated melanoma patients VM Vorwald, DM Davis, RJ Van Gulick, RJ Torphy, JSW Borgers, ... Clinical & Translational Immunology 11 (1), e1367, 2022 | 20 | 2022 |
| High-dimensional analysis of postsplenectomy peripheral immune cell changes JSW Borgers, RP Tobin, VM Vorwald, JM Smith, DM Davis, AK Kimball, ... Immunohorizons 4 (2), 82-92, 2020 | 12 | 2020 |
| Melanoma metastases to the adrenal gland are highly resistant to immune checkpoint inhibitors JSW Borgers, RP Tobin, RJ Torphy, VM Vorwald, RJ Van Gulick, ... Journal of the National Comprehensive Cancer Network 19 (13), 53-63, 2021 | 10 | 2021 |
| Pembrolizumab and all-trans retinoic acid combination treatment of advanced melanoma. M McCarter, RP Tobin, DT Cogswell, VM Vorwald, D Davis, RJ Van Gulick, ... Journal of Clinical Oncology 39 (15_suppl), 9536-9536, 2021 | 5 | 2021 |
| Investigating the role of NF-κB signaling and immune checkpoint blockade therapy in melanoma K Wells, J Hintzsche, CM Amato, R Tobin, V Vorwald, M McCarter, ... Cancer Research 79 (13_Supplement), 5002-5002, 2019 | 3 | 2019 |
| Immune Checkpoint Inhibitors in Melanoma of Unknown Primary F Ho, RJ Torphy, RP Tobin, JS Borgers, VM Vorwald, CA Amato, ... ANNALS OF SURGICAL ONCOLOGY 28 (SUPPL 1), S105-S106, 2021 | | 2021 |
| Abstract A117: Tumor-produced IL-6 and IL-8 are associated with MDSC accumulation and correlate with long-term clinical outcomes in melanoma patients RP Tobin, KR Jordan, D Davis, VM Vorwald, K Couts, D Gao, DE Smith, ... Cancer Immunology Research 7 (2_Supplement), A117-A117, 2019 | | 2019 |
| Articles in PresS. J Appl Physiol (November 10, 2016). doi: 10.1152/japplphysiol. 00732.2016 JR Santos-Parker, TR Strahler, VM Vorwald, GL Pierce, DR Seals | | 2016 |
